Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.01% | $22.48M | €401.77B | 41.34% | 76 Outperform | |
| Roche Holding AG | 1.88% | $14.05M | CHF270.15B | 45.02% | 73 Outperform | |
| AstraZeneca | 1.88% | $14.01M | £220.54B | 29.01% | 80 Outperform | |
| HSBC Holdings | 1.74% | $12.99M | £204.52B | 48.96% | 80 Outperform | |
| Novartis AG | 1.72% | $12.84M | CHF216.20B | 24.14% | 80 Outperform | |
| SAP SE | 1.57% | $11.69M | €237.28B | -15.64% | 66 Neutral | |
| Nestlé SA | 1.52% | $11.35M | CHF188.36B | 12.31% | 71 Outperform | |
| Siemens | 1.42% | $10.61M | €199.94B | 30.63% | 74 Outperform | |
| Shell (UK) | 1.30% | $9.71M | £151.07B | -1.97% | 73 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.16% | $8.68M | €312.82B | -1.45% | 78 Outperform |